Central Valley Advisors’s AbbVie ABBV Stock Holding History

Central Valley Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$493K	Hold	1,883	–	–	0.13%	104
2026 Q2	$474K	Buy	1,883 +3	+0.2%	+$645	0.12%	121
2026 Q1	$409K	Hold	1,880	–	–	0.11%	128
2025 Q4	$430K	Hold	1,880	–	–	0.13%	105
2025 Q3	$435K	Buy	1,880 +5	+0.3%	+$1.02K	0.13%	106
2025 Q2	$348K	Sell	1,875 -8	-0.4%	-$1.49K	0.12%	104
2025 Q1	$395K	Sell	1,883 -219	-10%	-$42.6K	0.15%	86
2024 Q4	$374K	Buy	2,102 +2	+0.1%	+$368	0.17%	99
2024 Q3	$415K	Sell	2,100 -3	-0.1%	-$560	0.23%	80
2024 Q2	$361K	Hold	2,103	–	–	0.15%	81
2024 Q1	$383K	Sell	2,103 -10	-0.5%	-$1.72K	0.2%	93
2023 Q4	$327K	Buy	+2,113	New	+$308K	0.19%	107

Other funds holding ABBV

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Central Valley Advisors's ABBV Position: Q3 2026 in Review

Central Valley Advisors held its AbbVie (ABBV) position steady in Q3 2026 at 1,883 shares worth $493K. The position accounts for 0.13% of the portfolio, ranked #104.

Central Valley Advisors first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. 2,892 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Central Valley Advisors held 1,883 shares of AbbVie worth $493K as of Q3 2026.
Central Valley Advisors left its AbbVie share count unchanged in Q3 2026.
AbbVie made up 0.13% of Central Valley Advisors's portfolio in Q3 2026, its #104 holding.
Central Valley Advisors first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
2,892 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Central Valley Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.